{"article_title": "Can Dividend Stocks Novo Nordisk and Novartis Continue to Perform? -- The Motley Fool", "article_keywords": ["novo", "fool", "great", "williamson", "threats", "nordisk", "start", "motley", "sp", "opportunities", "novartis", "perform", "continue", "video", "dividend", "stocks", "theyve"], "article_url": "http://www.fool.com/investing/general/2014/07/08/can-dividend-stocks-novo-nordisk-and-novartis-cont.aspx", "article_text": "Novo Nordisk (NYSE:NVO) and Novartis (NYSE:NVS) have had a great start to their 2014, with shares climbing around 25% and 16%, respectively. And both pay a dividend -- Novo's is around 1.8%, while Novartis' is 3%, according to S&P Capital IQ. So they've had a great year so far, and income investors should keep an eye on them. But can they continue to outperform? Both stocks have opportunities to expand and threats from competitors coming online with new drugs.\n\nIn the video below, Motley Fool health care analysts Michael Douglass and David Williamson give their take on the two stocks and what they see as the opportunities and threats for each.", "article_metadata": {"publish_time": "10:26", "date": "2014-07-08T14:26:00Z", "description": "Dividends and growth -- watch below to learn more about these stocks", "ResponsiveALP": "1Ses_2things-v-single_single-control_50", "author": "Michael Douglass and Dave Williamson", "promo": "Dividends and growth -- watch below to learn more about these stocks", "twitter": {"description": "Dividends and growth -- watch below to learn more about these stocks", "site": "@themotleyfool", "title": "Can Dividend Stocks Novo Nordisk and Novartis Continue to Perform? --  The Motley Fool"}, "headline": "Can Dividend Stocks Novo Nordisk and Novartis Continue to Perform?", "og": {"site_name": "The Motley Fool", "description": "Dividends and growth -- watch below to learn more about these stocks", "title": "Can Dividend Stocks Novo Nordisk and Novartis Continue to Perform? --  The Motley Fool", "url": "http://www.fool.com/investing/general/2014/07/08/can-dividend-stocks-novo-nordisk-and-novartis-cont.aspx", "image": "https://g.foolcdn.com/image/?url=http%3A%2F%2Fg.foolcdn.com%2Fassets%2Fimages%2Ffool%2Ftmf-logo.png&h=630&w=1200&op=resize", "type": "article"}, "fb": {"admins": 50808187550, "page_id": 7240312795, "app_id": 50808187550}, "bureau": "usmf-health-care", "STORY_UID": "751049b2-05d4-11e4-8c0b-0050569d4be0", "pitch": 787, "msvalidate.01": "8D40D58712924715BAA79D135A6C8DDA", "gsa_date": "2014 07 08", "tickers": "NVO,LLY,NVS", "viewport": "width=device-width, initial-scale=1.0, maximum-scale=1.0"}, "_id": "\"57477af46914bd0286fe2671\"", "article_summary": "Novo Nordisk (NYSE:NVO) and Novartis (NYSE:NVS) have had a great start to their 2014, with shares climbing around 25% and 16%, respectively.\nAnd both pay a dividend -- Novo's is around 1.8%, while Novartis' is 3%, according to S&P Capital IQ.\nBoth stocks have opportunities to expand and threats from competitors coming online with new drugs.\nIn the video below, Motley Fool health care analysts Michael Douglass and David Williamson give their take on the two stocks and what they see as the opportunities and threats for each.\nSo they've had a great year so far, and income investors should keep an eye on them."}